Feb 5 2024: A second chemist (thank you, Y.) has weighed in on the identification of the tentatively identified substance (Voacangine) in this sample.
Jan 30 2024: The unidentified substance appears to be Voacangine. Our lab does not currently have a certified reference standard for Voacangine, but one is available. It might be months before we see the results of any new analysis compared to the Voacangine standard. Check back for updates.
The mass spectrum for this sample is pictured below, left.
Send in a sample for testing
DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.
Should the public have access to independent analysis of the products they consume?
The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.
DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.
Mar 1 2024: Sample contains voacangine, confirmed by comparison to certified reference standard.
Jan 30 2024: The unidentified substance appears to be Voacangine. Our lab does not currently have a certified reference standard for Voacangine, but one is available. It might be months before we see the results of any new analysis compared to the Voacangine standard. Check back for updates.
The mass spectrum for this sample is pictured below, left.